22 episodes

OUR MISSION
To facilitate tangible improvements in the lives of people who have been affected by cancer(s), by providing them and their loved ones the necessary survival tools, education, support and advocacy so that they can become responsible for and take an active role in their own medical care and wellbeing.
OUR GOAL
Our goal is to teach all people affected by cancer, including those with multiple cancers and/or rare cancers, to become CANCER THRIVERS.

Cancer ABCs From Surviving To Thriving - How to Thrive with Cancer Joel Nowak Cancer ABCs

    • Health & Fitness
    • 4.8 • 6 Ratings

OUR MISSION
To facilitate tangible improvements in the lives of people who have been affected by cancer(s), by providing them and their loved ones the necessary survival tools, education, support and advocacy so that they can become responsible for and take an active role in their own medical care and wellbeing.
OUR GOAL
Our goal is to teach all people affected by cancer, including those with multiple cancers and/or rare cancers, to become CANCER THRIVERS.

    Methotrexate and the COVID Vaccine -WARNING

    Methotrexate and the COVID Vaccine -WARNING

    https://ard.bmj.com/content/early/2021/08/22/annrheumdis-2021-220597
     As per the link above, individuals taking the drug methotrexate experience an up to 62% reduced rate of an immunological response when given a mRNA Covid-19 vaccination like to Pfizer and Moderna vaccines.  This finding suggests that patients on methotrexate may need alternate vaccination strategies such as additional doses of vaccine, dose modification of methotrexate or even a temporary discontinuation of this drug.
    In this podcast, Joel Nowak from Cancer ABCs, who is taking methotrexate, after having is booster shot of the Moderna vaccine was informed by his doctor that he should have not received the injection without having made a modification in his methotrexate.   Joel talks about his frustration and anger that he was not informed about this complication when the research was first published, three months prior to his receiving his Covid-19 booster shot.  
     Joel shared his current plan to discontinue taking methotrexate and hope that the booster will still create some antigen effect.  He will follow up in a few weeks and check his antigen level (blood test) and then if he hasn't received an adequate result go on a campaign to obtain an additional Covid vaccination booster while still remaining off methotrexate.
    Joel’s story should serve as a warning to anyone taking methotrexate that they need to discuss this issue with their doctors prior to having a mRNA Covid-19 vaccination.  


    Cancer ABCs would like to thank its podcast sponsors for their support of this podcast program.  Our sponsors include:
    Myovant/PfizerFoundation MedicineBayer DendreonSupport the show (https://www.cancerabcs.org/new-page-2/)

    • 6 min
    A Special Message for Someone Diagnosed with Cancer

    A Special Message for Someone Diagnosed with Cancer

    When you are first diagnosed with cancer, when the doctor says to you have cancer, you are likely to have many different responses. Among these first possible responses are fear, apprehension, disbelief, sadness, anger, dread, or even denial. Any and all of these reactions are reasonable and normal.

    The question is how do you chose to deal with these feelings?  

    Everyone's cancer is different and how we as individuals deal with our cancer is also different. However, developing a specific mindset, taking personal responsibility for yourself and your medical care, learning about your disease and  deciding on how you are going to come to grips with your reality will immediately influence you today and tomorrow. 

    We all have choices to make, the choice we eventually make will have repercussions from today until the day we die.  Making better choices is hard, but so much of our future is dependent on the choices and decisions we make from today and on. 

    In this podcast, Joel Nowak shares some lessons he has learned about being diagnosed with cancer.  Joel has been told he has cancer on six different occasions.  He has been diagnosed with 5 different cancers (thyroid, renal (kidney), melanoma, prostate and appendiceal (appendix cancer) as well as a prostate cancer recurrence five years after his primary treatment. 

    Cancer ABCs would like to thank its podcast sponsors for their support of this podcast program.  Our sponsors include:
    Myovant/PfizerFoundation MedicineBayer Dendreon





    Support the show (https://www.cancerabcs.org/new-page-2/)

    • 7 min
    New Orleans Music Producer Shane Norris Diagnosed with Prostate Cancer During Covid Shares His Journey with HIFU Treatment

    New Orleans Music Producer Shane Norris Diagnosed with Prostate Cancer During Covid Shares His Journey with HIFU Treatment

    Joel Nowak and Shane Norris discuss his unusual Covid Pandemic Journey with a new prostate cancer diagnosis.  Shane, a well-respected music producer and gig worker, joined with other New Orleans artists to raise funds for out-of-work musicians.  As he began to create a fund raising vehicle he was diagnosed with prostate cancer.  

    Shane shares the experience he had navigating the Covid pandemic as he searched for the prostate cancer treatment that he felt best suited his needs.  With financial support raised from a GO-Fund-Me project as well as help and guidance from a number of resources, including medical professionals, family and friends, Shane decided to become the first man in Louisiana to treat his prostate cancer with high intensity focused ultrasound – or HIFU. 
    Despite Shane having to learn about prostate cancer and potential treatments and their possible side effects, in the middle of a pandemic, he and his colleagues managed to raise and distribute $400,000 to out-of-work New Orleans artists.   

    Some Important Additional Information:
     1-  High Intensity Focal Ultrasound (HIFU) currently has a CPT code, and is covered by Medicare, with a deductible. HIFU is also covered by some private insurance carriers for both initial treatment and as a salvage therapy.  Please check with your insurance carrier (Medicare and private carriers) to confirm your specific coverages.  With the CPT code urology practices can now submit claims to private insurers which are evaluated for reimbursement on a case by case basis. 
    2-  Shane's personal experience with side effects from his HIFU treatment does not guarantee that others having HIFU will have the same experience.  Following HIFU patients may be required to have a catheter inserted for 3 to 7 days.  The risk of having the more common side effects of urinary incontinence and sexual dysfunction seen in treating the entire gland are minimized due to HIFU's targeted nature of  tumor ablation. 

    Cancer ABCs would like to thank its podcast sponsors for their support of this podcast program.  Our sponsors include:
    Myovant/PfizerFoundation MedicineBayer Dendreon



     
    Support the show (https://www.cancerabcs.org/new-page-2/)

    • 26 min
    Understanding the Importance of Radiopharmaceutical Scans and Why They Might Not Be Available for Us When We Need Them

    Understanding the Importance of Radiopharmaceutical Scans and Why They Might Not Be Available for Us When We Need Them

    Radiopharmaceutical scans (PETS) are a vital tool in our fight against cancer. 

    These special PET scans allow us to make earlier cancer diagnoses while a cancer is still contained in the original organ.   With an earlier diagnosis, treatments can still stop the cancer before it is able to move to other parts of the body, or become metastatic.  

    These special scans also are our best tools to evaluate whether our treatments are working, or if we have developed resistance to the treatments.  FDA approved treatments are limited, so we have  to take full advantage of them while they work.  Since most treatments will eventually stop working, we need to also have an immediate and accurate way to measure whether we are still benefiting from our treatments, or have developed resistance to them.

    Sadly, the future of these scans is in jeopardy.  The current insurance reimbursement schedule only supports the use of these scans for three years, after which reimbursement rates might not cover the costs, making these very important scans unavailable despite having been approved by the FDA.  Currently these scans could be looking  at a 3 year life, after which adequate reimbursement might disappear (as will the availability of the scan to patients). 

    Cancer ABCs is working to change the law so that reimbursement of these scans will keep them affordable and available as we need them.  Join us and help us preserve the availability of these scans.  To learn more about this issue,  and to lend your support, reach out to us at info@CancerABCs.org

    Cancer ABCs would like to thank its podcast sponsors for their support of this podcast program.  Our sponsors include:
    Myovant/PfizerFoundation MedicineBayer Dendreon




    Support the show (https://www.cancerabcs.org/new-page-2/)

    • 12 min
    Survival with Provenge - Real World Data Along with A Peek Into the Future of Treatment

    Survival with Provenge - Real World Data Along with A Peek Into the Future of Treatment

    Joel T Nowak from Cancer ABCs discusses with Dr. Rana McKay, Associate Professor of Medicine at the Moores Cancer Center at the University of California in San Diego,  her recently published article that analysizes real world data that demonstrates that Provenge (sipuleucel-T), an immune therapy for castrate  resistant metastatic prostate cancer (mCRPC), can reduce the risk of death over and above the newer  hormone treatments that have been FDA approved . 

    Dr, McKay evaluated a large medicare data base and determined that despite the addition of the many second generation hormone treatments like Zytiga and Xtandi,  Provenge continues to lower the risk of death for men with mCRPC.  

    Dr. Mckay also shared a peek into the future of additional immune therapies for prostate cancer as well as sharing information about the newly FDA approved part inhibitors.  

    Cancer ABCs would like to thank its podcast sponsors for their support of this podcast program.  Our sponsors include:
    Myovant/PfizerFoundation MedicineBayer DendreonSupport the show (https://www.cancerabcs.org/new-page-2/)

    • 25 min
    Is ADT Hormone Therapy Necessary When You Take Abiraterone Acetate aka Zytiga?

    Is ADT Hormone Therapy Necessary When You Take Abiraterone Acetate aka Zytiga?

    One of the most common question men with prostate cancer ask us at Cancer ABCs is if they can stop their hormone therapy (ADT) when they go on a second generation hormone treatment like abiraterone (Zytiga).

    A recent analysis of the SPARE Trial points us in the direction that it might be possible to halt ADT when you are taking Zytiga.  SPARE was a small trial which needs to be replicated by a larger trial before we can gain confidence in this conclusion. 

    SPARE did not evaluate what, if any change. stopping ADT  when you are on Zytiga might have on survival, economic costs and the quality of life.  
    Support the show (https://www.cancerabcs.org/new-page-2/)

    • 6 min

Customer Reviews

4.8 out of 5
6 Ratings

6 Ratings

ketotruck ,

One of the better cancer websites just got a great podcast

This is one of the better websites. I have advanced prostate cancer and I am learning so much about thriving with this disease. The podcast is very informative.

Charlie and friend ,

Terrific Podcast

Cancer is a difficult topic to present well to a wide audience for many reasons. This podcast makes complicated material understandable and useful to a variety of listeners without in any way losing any of the important details. Looking forward to more of these, particularly interviews of the people truly in the trenches. Thanks, Joel T. Nowak and Cancer ABCs.

bsnoa ,

Cancer abcs

Very informative podcast. I learned an enormous amount. Thanks.

Top Podcasts In Health & Fitness

Aubrey Gordon & Michael Hobbes
Scicomm Media
Jay Shetty
Scicomm Media
Slumber Studios
Ten Percent Happier